Contents
When to Worry About Blood in Your Urine: New Guidelines Explained
Published: Feb 05, 2024
Blood in urine can be scary, but not all cases require extensive testing. New guidelines help doctors decide who needs further evaluation. Understanding these can help you make informed decisions about your health.
The Risk-Based Approach
The American Urological Association (AUA) has introduced a risk-based approach to evaluating blood in urine. This system categorizes patients as low, intermediate, or high risk for urinary tract cancer. Factors like age, gender, smoking history, and the amount of blood in urine are considered. This approach aims to reduce unnecessary testing while ensuring high-risk patients get thorough evaluations.
Who Needs Further Testing?
According to the guidelines, all patients with visible blood in their urine should be evaluated. For microscopic blood (only visible under a microscope), the approach varies. High-risk patients typically need imaging tests and a procedure called cystoscopy to look inside the bladder. Intermediate-risk patients may have ultrasound and cystoscopy. For low-risk patients, repeating the urine test in a few months might be enough.
Special Considerations
The guidelines also address special populations. For instance, patients with sickle cell trait or a family history of kidney cancer may need more thorough evaluation regardless of their risk category. Pregnant women typically start with ultrasound rather than CT scans. The guidelines also emphasize that blood thinners are not an excuse to skip evaluation - these patients still need to be checked for underlying causes.
Follow-Up Recommendations
Even after a negative evaluation, some patients need follow-up. The guidelines suggest repeating urine tests within a year for those with persistent blood in urine. If blood reappears or new symptoms develop, a full re-evaluation may be needed. The goal is to balance thorough care with avoiding unnecessary procedures.
Frequently Asked Questions
It depends on your risk factors; consult your doctor.
Guidelines suggest within 12 months for persistent cases.
They're from the AUA, but similar approaches are used elsewhere.
Most do, but individual cases may vary.
Yes, discuss your concerns with your doctor.
Personalized Care is Key
While guidelines provide a framework, your doctor will consider your individual situation when making recommendations.
References
- Barocas DA, Boorjian SA, Alvarez RD, et al. Microhematuria: AUA/SUFU Guideline. J Urol 2020; 204:778.
- Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clin Proc 2013; 88:129.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?